Guilingan, Jesel .

HRN: 27-89-43  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2025
CEFUROXIME 1.5GM (VIAL)
10/21/2025
10/21/2025
IV
1.5g
PTOR
For USO
Waiting Final Action 
10/22/2025
CEFUROXIME 500MG (TAB)
10/22/2025
10/29/2025
ORAL
500 Mg
Bid
S/p Right Uso
Waiting Final Action 
10/24/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
10/24/2025
10/31/2025
PO
5mL
TID
Oral Ulcer
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: